Valvular & structural heart disease

Heart Failure After Left Atrial Appendage Occlusion: Insights from the LAAOS III Randomized Trial

Eur J Heart FailPublished Secondary analysis of the LAAOS III randomised trial

Primary result · Composite HF outcomeResult — go to the resultHazard ratio 1.12 95% CI 0.92–1.37

Authors' conclusion

Left atrial appendage occlusion or removal at the time of cardiac surgery does not appear to alter the risk of HF-related hospitalization or death.

Study context

Population
Patients with atrial fibrillation (AF) and CHA2DS2-VASc score ≥2 having cardiac surgery for another indication
Participants
4,811 patients
Comparison
Surgical LAAO vs no LAAO during cardiac surgery
  • LAAOn = 2,379
  • Without LAAOn = 2,391reference
Primary endpoint
Composite of:
  • HF-related hospitalizations
  • HF death
Follow-up
Mean 3.8 years
Methodological detailslandmark analysis
  • Landmark analysis

Primary result

Composite HF outcome

Hazard ratio

1.12

95% CI 0.92–1.37

P = 0.25

Events by treatment group

LAAOvs Without LAAO
HR 1.12 (95% CI 0.92–1.37); P = 0.25

As reported in the abstract

Further findings

Composite HF outcome, first 30 days (landmark)

P = 0.12

Composite HF outcome, after 30 days (landmark)

P = 0.57

OutcomeHR (95% CI)P value
HF outcomes by closure method (subgroup)Cut-and-sew0.93 (0.70–1.23)P = 0.62
HF outcomes by closure method (subgroup)Other closure methods1.05 (0.77–1.41)P = 0.77

Heart failure (HF) outcomes by subgroup (age, sex, BMI, AF type, prior HF, cardiac rhythm, LVEF)

Consistent results across subgroups

Original publication

Heart Failure After Left Atrial Appendage Occlusion: Insights from the LAAOS III Randomized Trial. Eur J Heart Fail. Published 25 November 2024. doi:10.1002/ejhf.3536

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.